AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery. Company also announces ...

A new study from Oregon Health & Science University has uncovered how small molecules within bacteria interact with proteins, ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Relay Therapeutics Inc. (NASDAQ:RLAY) is a leading clinical-stage precision medicines firm focused on cancer treatments. The ...

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...

VALID, a Techbio startup dedicated to reshaping drug discovery with complex human induced pluripotent stem cell (iPSC) co-culture models that deliver increased predictive validity, has partnered with ...

In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of ...

Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.

A global team has made a significant advance in understanding how bacterial plasmids contribute to antibiotic resistance.

To tackle a backlog in toxicity testing, US federal scientists are modernizing programs with high-throughput assays and AI.

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...